Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-07

FDA Approved: NABUMETONE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' original application for nabumetone, a nonsteroidal anti-inflammatory drug used to relieve pain in osteoarthritis and rheu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nabumetone (Nabumetone)

Snippet

ORIG AP for NABUMETONE (NABUMETONE)